nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefazolin—ABCC4—Sorafenib—thyroid cancer	0.428	0.619	CbGbCtD
Cefazolin—ALB—Vandetanib—thyroid cancer	0.264	0.381	CbGbCtD
Cefazolin—Nephropathy—Vandetanib—thyroid cancer	0.013	0.0422	CcSEcCtD
Cefazolin—Tubulointerstitial nephritis—Vandetanib—thyroid cancer	0.00809	0.0262	CcSEcCtD
Cefazolin—Blood bilirubin increased—Vandetanib—thyroid cancer	0.00655	0.0212	CcSEcCtD
Cefazolin—Creatinine increased—Vandetanib—thyroid cancer	0.0065	0.0211	CcSEcCtD
Cefazolin—Colitis—Vandetanib—thyroid cancer	0.00594	0.0193	CcSEcCtD
Cefazolin—Tubulointerstitial nephritis—Sorafenib—thyroid cancer	0.00545	0.0177	CcSEcCtD
Cefazolin—Blood bilirubin increased—Sorafenib—thyroid cancer	0.00442	0.0143	CcSEcCtD
Cefazolin—Blood creatinine increased—Vandetanib—thyroid cancer	0.00421	0.0137	CcSEcCtD
Cefazolin—Mouth ulceration—Sorafenib—thyroid cancer	0.00378	0.0123	CcSEcCtD
Cefazolin—Prothrombin level increased—Epirubicin—thyroid cancer	0.00376	0.0122	CcSEcCtD
Cefazolin—Neutropenia—Vandetanib—thyroid cancer	0.00363	0.0118	CcSEcCtD
Cefazolin—Prothrombin level increased—Doxorubicin—thyroid cancer	0.00348	0.0113	CcSEcCtD
Cefazolin—Hepatic function abnormal—Sorafenib—thyroid cancer	0.00347	0.0113	CcSEcCtD
Cefazolin—Stevens-Johnson syndrome—Vandetanib—thyroid cancer	0.00343	0.0111	CcSEcCtD
Cefazolin—Renal failure—Vandetanib—thyroid cancer	0.0034	0.0111	CcSEcCtD
Cefazolin—Stomatitis—Vandetanib—thyroid cancer	0.00338	0.011	CcSEcCtD
Cefazolin—Haemoglobin—Vandetanib—thyroid cancer	0.00312	0.0101	CcSEcCtD
Cefazolin—Haemorrhage—Vandetanib—thyroid cancer	0.00311	0.0101	CcSEcCtD
Cefazolin—Lactic dehydrogenase activity increased—Epirubicin—thyroid cancer	0.00302	0.00979	CcSEcCtD
Cefazolin—Erythema multiforme—Vandetanib—thyroid cancer	0.00294	0.00954	CcSEcCtD
Cefazolin—Anorectal discomfort—Epirubicin—thyroid cancer	0.00282	0.00917	CcSEcCtD
Cefazolin—Lactic dehydrogenase activity increased—Doxorubicin—thyroid cancer	0.00279	0.00906	CcSEcCtD
Cefazolin—Local reaction—Epirubicin—thyroid cancer	0.00279	0.00905	CcSEcCtD
Cefazolin—Abdominal pain upper—Sorafenib—thyroid cancer	0.00277	0.00899	CcSEcCtD
Cefazolin—Aspartate aminotransferase increased—Sorafenib—thyroid cancer	0.00273	0.00886	CcSEcCtD
Cefazolin—Toxic epidermal necrolysis—Sorafenib—thyroid cancer	0.00273	0.00886	CcSEcCtD
Cefazolin—Blood lactate dehydrogenase increased—Epirubicin—thyroid cancer	0.00266	0.00862	CcSEcCtD
Cefazolin—Anorectal discomfort—Doxorubicin—thyroid cancer	0.00261	0.00848	CcSEcCtD
Cefazolin—Local reaction—Doxorubicin—thyroid cancer	0.00258	0.00837	CcSEcCtD
Cefazolin—Thrombocytosis—Epirubicin—thyroid cancer	0.00248	0.00806	CcSEcCtD
Cefazolin—Blood lactate dehydrogenase increased—Doxorubicin—thyroid cancer	0.00246	0.00798	CcSEcCtD
Cefazolin—Neutropenia—Sorafenib—thyroid cancer	0.00245	0.00795	CcSEcCtD
Cefazolin—Oral candidiasis—Epirubicin—thyroid cancer	0.00243	0.00789	CcSEcCtD
Cefazolin—Loss of consciousness—Vandetanib—thyroid cancer	0.00238	0.00772	CcSEcCtD
Cefazolin—Convulsion—Vandetanib—thyroid cancer	0.00235	0.00761	CcSEcCtD
Cefazolin—Stevens-Johnson syndrome—Sorafenib—thyroid cancer	0.00232	0.00752	CcSEcCtD
Cefazolin—Thrombocytosis—Doxorubicin—thyroid cancer	0.0023	0.00746	CcSEcCtD
Cefazolin—Renal failure—Sorafenib—thyroid cancer	0.0023	0.00746	CcSEcCtD
Cefazolin—Stomatitis—Sorafenib—thyroid cancer	0.00228	0.00739	CcSEcCtD
Cefazolin—Oral candidiasis—Doxorubicin—thyroid cancer	0.00225	0.0073	CcSEcCtD
Cefazolin—Thrombocytopenia—Vandetanib—thyroid cancer	0.00216	0.00702	CcSEcCtD
Cefazolin—Haemoglobin—Sorafenib—thyroid cancer	0.00211	0.00684	CcSEcCtD
Cefazolin—Haemorrhage—Sorafenib—thyroid cancer	0.0021	0.00681	CcSEcCtD
Cefazolin—Erythema multiforme—Sorafenib—thyroid cancer	0.00198	0.00644	CcSEcCtD
Cefazolin—Dyspepsia—Vandetanib—thyroid cancer	0.00194	0.00631	CcSEcCtD
Cefazolin—Decreased appetite—Vandetanib—thyroid cancer	0.00192	0.00623	CcSEcCtD
Cefazolin—Fatigue—Vandetanib—thyroid cancer	0.0019	0.00618	CcSEcCtD
Cefazolin—Pain—Vandetanib—thyroid cancer	0.00189	0.00613	CcSEcCtD
Cefazolin—Blood disorder—Epirubicin—thyroid cancer	0.00185	0.006	CcSEcCtD
Cefazolin—Gastrointestinal pain—Vandetanib—thyroid cancer	0.00181	0.00586	CcSEcCtD
Cefazolin—Jaundice cholestatic—Epirubicin—thyroid cancer	0.00176	0.0057	CcSEcCtD
Cefazolin—Abdominal pain—Vandetanib—thyroid cancer	0.00175	0.00567	CcSEcCtD
Cefazolin—Body temperature increased—Vandetanib—thyroid cancer	0.00175	0.00567	CcSEcCtD
Cefazolin—Blood disorder—Doxorubicin—thyroid cancer	0.00171	0.00555	CcSEcCtD
Cefazolin—Anaemia—Sorafenib—thyroid cancer	0.00169	0.00548	CcSEcCtD
Cefazolin—Syncope—Sorafenib—thyroid cancer	0.00164	0.00532	CcSEcCtD
Cefazolin—Leukopenia—Sorafenib—thyroid cancer	0.00163	0.00531	CcSEcCtD
Cefazolin—Blood bilirubin increased—Epirubicin—thyroid cancer	0.00163	0.0053	CcSEcCtD
Cefazolin—Jaundice cholestatic—Doxorubicin—thyroid cancer	0.00163	0.00528	CcSEcCtD
Cefazolin—Creatinine increased—Epirubicin—thyroid cancer	0.00162	0.00526	CcSEcCtD
Cefazolin—Loss of consciousness—Sorafenib—thyroid cancer	0.0016	0.00521	CcSEcCtD
Cefazolin—Asthenia—Vandetanib—thyroid cancer	0.00158	0.00514	CcSEcCtD
Cefazolin—Pruritus—Vandetanib—thyroid cancer	0.00156	0.00507	CcSEcCtD
Cefazolin—Vaginal inflammation—Epirubicin—thyroid cancer	0.00154	0.00501	CcSEcCtD
Cefazolin—Diarrhoea—Vandetanib—thyroid cancer	0.00151	0.00491	CcSEcCtD
Cefazolin—Blood bilirubin increased—Doxorubicin—thyroid cancer	0.00151	0.0049	CcSEcCtD
Cefazolin—Creatinine increased—Doxorubicin—thyroid cancer	0.0015	0.00487	CcSEcCtD
Cefazolin—Anaphylactic shock—Sorafenib—thyroid cancer	0.00149	0.00484	CcSEcCtD
Cefazolin—Colitis—Epirubicin—thyroid cancer	0.00148	0.00481	CcSEcCtD
Cefazolin—Candida infection—Epirubicin—thyroid cancer	0.00147	0.00478	CcSEcCtD
Cefazolin—Shock—Sorafenib—thyroid cancer	0.00147	0.00476	CcSEcCtD
Cefazolin—Dizziness—Vandetanib—thyroid cancer	0.00146	0.00474	CcSEcCtD
Cefazolin—Thrombocytopenia—Sorafenib—thyroid cancer	0.00146	0.00474	CcSEcCtD
Cefazolin—Vaginal infection—Epirubicin—thyroid cancer	0.00146	0.00473	CcSEcCtD
Cefazolin—Blood urea increased—Epirubicin—thyroid cancer	0.00146	0.00473	CcSEcCtD
Cefazolin—Aplastic anaemia—Epirubicin—thyroid cancer	0.00145	0.0047	CcSEcCtD
Cefazolin—Vaginal inflammation—Doxorubicin—thyroid cancer	0.00143	0.00464	CcSEcCtD
Cefazolin—Anorexia—Sorafenib—thyroid cancer	0.00142	0.00461	CcSEcCtD
Cefazolin—Vomiting—Vandetanib—thyroid cancer	0.0014	0.00456	CcSEcCtD
Cefazolin—Mouth ulceration—Epirubicin—thyroid cancer	0.0014	0.00453	CcSEcCtD
Cefazolin—Rash—Vandetanib—thyroid cancer	0.00139	0.00452	CcSEcCtD
Cefazolin—Dermatitis—Vandetanib—thyroid cancer	0.00139	0.00452	CcSEcCtD
Cefazolin—Headache—Vandetanib—thyroid cancer	0.00138	0.00449	CcSEcCtD
Cefazolin—Colitis—Doxorubicin—thyroid cancer	0.00137	0.00445	CcSEcCtD
Cefazolin—Candida infection—Doxorubicin—thyroid cancer	0.00136	0.00443	CcSEcCtD
Cefazolin—Hypertonia—Epirubicin—thyroid cancer	0.00135	0.00439	CcSEcCtD
Cefazolin—Vaginal infection—Doxorubicin—thyroid cancer	0.00135	0.00438	CcSEcCtD
Cefazolin—Blood urea increased—Doxorubicin—thyroid cancer	0.00135	0.00438	CcSEcCtD
Cefazolin—Aplastic anaemia—Doxorubicin—thyroid cancer	0.00134	0.00435	CcSEcCtD
Cefazolin—Nausea—Vandetanib—thyroid cancer	0.00131	0.00426	CcSEcCtD
Cefazolin—Dyspepsia—Sorafenib—thyroid cancer	0.00131	0.00426	CcSEcCtD
Cefazolin—Phlebitis—Epirubicin—thyroid cancer	0.0013	0.00422	CcSEcCtD
Cefazolin—Decreased appetite—Sorafenib—thyroid cancer	0.0013	0.00421	CcSEcCtD
Cefazolin—Mouth ulceration—Doxorubicin—thyroid cancer	0.00129	0.00419	CcSEcCtD
Cefazolin—Fatigue—Sorafenib—thyroid cancer	0.00128	0.00417	CcSEcCtD
Cefazolin—Hepatic function abnormal—Epirubicin—thyroid cancer	0.00128	0.00416	CcSEcCtD
Cefazolin—Pain—Sorafenib—thyroid cancer	0.00127	0.00414	CcSEcCtD
Cefazolin—Hypertonia—Doxorubicin—thyroid cancer	0.00125	0.00406	CcSEcCtD
Cefazolin—Gastrointestinal pain—Sorafenib—thyroid cancer	0.00122	0.00396	CcSEcCtD
Cefazolin—Phlebitis—Doxorubicin—thyroid cancer	0.0012	0.00391	CcSEcCtD
Cefazolin—Hepatic function abnormal—Doxorubicin—thyroid cancer	0.00119	0.00385	CcSEcCtD
Cefazolin—Urticaria—Sorafenib—thyroid cancer	0.00118	0.00384	CcSEcCtD
Cefazolin—Abdominal pain—Sorafenib—thyroid cancer	0.00118	0.00382	CcSEcCtD
Cefazolin—Body temperature increased—Sorafenib—thyroid cancer	0.00118	0.00382	CcSEcCtD
Cefazolin—Hypersensitivity—Sorafenib—thyroid cancer	0.0011	0.00356	CcSEcCtD
Cefazolin—Asthenia—Sorafenib—thyroid cancer	0.00107	0.00347	CcSEcCtD
Cefazolin—Pruritus—Sorafenib—thyroid cancer	0.00105	0.00342	CcSEcCtD
Cefazolin—Blood creatinine increased—Epirubicin—thyroid cancer	0.00105	0.00341	CcSEcCtD
Cefazolin—Abdominal pain upper—Epirubicin—thyroid cancer	0.00102	0.00332	CcSEcCtD
Cefazolin—Diarrhoea—Sorafenib—thyroid cancer	0.00102	0.00331	CcSEcCtD
Cefazolin—Toxic epidermal necrolysis—Epirubicin—thyroid cancer	0.00101	0.00328	CcSEcCtD
Cefazolin—Aspartate aminotransferase increased—Epirubicin—thyroid cancer	0.00101	0.00328	CcSEcCtD
Cefazolin—Dizziness—Sorafenib—thyroid cancer	0.000985	0.0032	CcSEcCtD
Cefazolin—Blood creatinine increased—Doxorubicin—thyroid cancer	0.000971	0.00315	CcSEcCtD
Cefazolin—Eosinophilia—Epirubicin—thyroid cancer	0.000959	0.00311	CcSEcCtD
Cefazolin—Vomiting—Sorafenib—thyroid cancer	0.000947	0.00308	CcSEcCtD
Cefazolin—Abdominal pain upper—Doxorubicin—thyroid cancer	0.000947	0.00307	CcSEcCtD
Cefazolin—Rash—Sorafenib—thyroid cancer	0.00094	0.00305	CcSEcCtD
Cefazolin—Dermatitis—Sorafenib—thyroid cancer	0.000939	0.00305	CcSEcCtD
Cefazolin—Toxic epidermal necrolysis—Doxorubicin—thyroid cancer	0.000934	0.00303	CcSEcCtD
Cefazolin—Aspartate aminotransferase increased—Doxorubicin—thyroid cancer	0.000934	0.00303	CcSEcCtD
Cefazolin—Headache—Sorafenib—thyroid cancer	0.000933	0.00303	CcSEcCtD
Cefazolin—Pancytopenia—Epirubicin—thyroid cancer	0.00092	0.00299	CcSEcCtD
Cefazolin—Neutropenia—Epirubicin—thyroid cancer	0.000906	0.00294	CcSEcCtD
Cefazolin—Eosinophilia—Doxorubicin—thyroid cancer	0.000887	0.00288	CcSEcCtD
Cefazolin—Nausea—Sorafenib—thyroid cancer	0.000885	0.00287	CcSEcCtD
Cefazolin—Stevens-Johnson syndrome—Epirubicin—thyroid cancer	0.000856	0.00278	CcSEcCtD
Cefazolin—Pancytopenia—Doxorubicin—thyroid cancer	0.000851	0.00276	CcSEcCtD
Cefazolin—Renal failure—Epirubicin—thyroid cancer	0.000849	0.00276	CcSEcCtD
Cefazolin—Stomatitis—Epirubicin—thyroid cancer	0.000842	0.00273	CcSEcCtD
Cefazolin—Neutropenia—Doxorubicin—thyroid cancer	0.000838	0.00272	CcSEcCtD
Cefazolin—Agranulocytosis—Epirubicin—thyroid cancer	0.000806	0.00262	CcSEcCtD
Cefazolin—Stevens-Johnson syndrome—Doxorubicin—thyroid cancer	0.000792	0.00257	CcSEcCtD
Cefazolin—Renal failure—Doxorubicin—thyroid cancer	0.000785	0.00255	CcSEcCtD
Cefazolin—Haemoglobin—Epirubicin—thyroid cancer	0.000779	0.00253	CcSEcCtD
Cefazolin—Stomatitis—Doxorubicin—thyroid cancer	0.000779	0.00253	CcSEcCtD
Cefazolin—Haemorrhage—Epirubicin—thyroid cancer	0.000775	0.00252	CcSEcCtD
Cefazolin—Hepatitis—Epirubicin—thyroid cancer	0.000775	0.00252	CcSEcCtD
Cefazolin—Agranulocytosis—Doxorubicin—thyroid cancer	0.000746	0.00242	CcSEcCtD
Cefazolin—Erythema multiforme—Epirubicin—thyroid cancer	0.000733	0.00238	CcSEcCtD
Cefazolin—Haemoglobin—Doxorubicin—thyroid cancer	0.000721	0.00234	CcSEcCtD
Cefazolin—Hepatitis—Doxorubicin—thyroid cancer	0.000717	0.00233	CcSEcCtD
Cefazolin—Haemorrhage—Doxorubicin—thyroid cancer	0.000717	0.00233	CcSEcCtD
Cefazolin—Erythema multiforme—Doxorubicin—thyroid cancer	0.000678	0.0022	CcSEcCtD
Cefazolin—Flatulence—Epirubicin—thyroid cancer	0.000665	0.00216	CcSEcCtD
Cefazolin—Anaemia—Epirubicin—thyroid cancer	0.000624	0.00202	CcSEcCtD
Cefazolin—Agitation—Epirubicin—thyroid cancer	0.00062	0.00201	CcSEcCtD
Cefazolin—Flatulence—Doxorubicin—thyroid cancer	0.000615	0.002	CcSEcCtD
Cefazolin—Syncope—Epirubicin—thyroid cancer	0.000605	0.00196	CcSEcCtD
Cefazolin—Leukopenia—Epirubicin—thyroid cancer	0.000604	0.00196	CcSEcCtD
Cefazolin—Loss of consciousness—Epirubicin—thyroid cancer	0.000593	0.00193	CcSEcCtD
Cefazolin—Convulsion—Epirubicin—thyroid cancer	0.000585	0.0019	CcSEcCtD
Cefazolin—Anaemia—Doxorubicin—thyroid cancer	0.000577	0.00187	CcSEcCtD
Cefazolin—Agitation—Doxorubicin—thyroid cancer	0.000574	0.00186	CcSEcCtD
Cefazolin—Syncope—Doxorubicin—thyroid cancer	0.00056	0.00182	CcSEcCtD
Cefazolin—Leukopenia—Doxorubicin—thyroid cancer	0.000559	0.00181	CcSEcCtD
Cefazolin—Confusional state—Epirubicin—thyroid cancer	0.000555	0.0018	CcSEcCtD
Cefazolin—Anaphylactic shock—Epirubicin—thyroid cancer	0.000551	0.00179	CcSEcCtD
Cefazolin—Loss of consciousness—Doxorubicin—thyroid cancer	0.000549	0.00178	CcSEcCtD
Cefazolin—Shock—Epirubicin—thyroid cancer	0.000542	0.00176	CcSEcCtD
Cefazolin—Convulsion—Doxorubicin—thyroid cancer	0.000541	0.00176	CcSEcCtD
Cefazolin—Thrombocytopenia—Epirubicin—thyroid cancer	0.000539	0.00175	CcSEcCtD
Cefazolin—Anorexia—Epirubicin—thyroid cancer	0.000525	0.0017	CcSEcCtD
Cefazolin—Hypotension—Epirubicin—thyroid cancer	0.000515	0.00167	CcSEcCtD
Cefazolin—Confusional state—Doxorubicin—thyroid cancer	0.000514	0.00167	CcSEcCtD
Cefazolin—Anaphylactic shock—Doxorubicin—thyroid cancer	0.00051	0.00165	CcSEcCtD
Cefazolin—Shock—Doxorubicin—thyroid cancer	0.000501	0.00163	CcSEcCtD
Cefazolin—Thrombocytopenia—Doxorubicin—thyroid cancer	0.000499	0.00162	CcSEcCtD
Cefazolin—Somnolence—Epirubicin—thyroid cancer	0.00049	0.00159	CcSEcCtD
Cefazolin—Anorexia—Doxorubicin—thyroid cancer	0.000486	0.00158	CcSEcCtD
Cefazolin—Dyspepsia—Epirubicin—thyroid cancer	0.000485	0.00157	CcSEcCtD
Cefazolin—Decreased appetite—Epirubicin—thyroid cancer	0.000479	0.00155	CcSEcCtD
Cefazolin—Hypotension—Doxorubicin—thyroid cancer	0.000476	0.00155	CcSEcCtD
Cefazolin—Fatigue—Epirubicin—thyroid cancer	0.000475	0.00154	CcSEcCtD
Cefazolin—Pain—Epirubicin—thyroid cancer	0.000471	0.00153	CcSEcCtD
Cefazolin—Feeling abnormal—Epirubicin—thyroid cancer	0.000454	0.00147	CcSEcCtD
Cefazolin—Somnolence—Doxorubicin—thyroid cancer	0.000453	0.00147	CcSEcCtD
Cefazolin—Gastrointestinal pain—Epirubicin—thyroid cancer	0.00045	0.00146	CcSEcCtD
Cefazolin—Dyspepsia—Doxorubicin—thyroid cancer	0.000449	0.00146	CcSEcCtD
Cefazolin—Decreased appetite—Doxorubicin—thyroid cancer	0.000443	0.00144	CcSEcCtD
Cefazolin—Fatigue—Doxorubicin—thyroid cancer	0.000439	0.00143	CcSEcCtD
Cefazolin—Urticaria—Epirubicin—thyroid cancer	0.000437	0.00142	CcSEcCtD
Cefazolin—Pain—Doxorubicin—thyroid cancer	0.000436	0.00141	CcSEcCtD
Cefazolin—Abdominal pain—Epirubicin—thyroid cancer	0.000435	0.00141	CcSEcCtD
Cefazolin—Body temperature increased—Epirubicin—thyroid cancer	0.000435	0.00141	CcSEcCtD
Cefazolin—Feeling abnormal—Doxorubicin—thyroid cancer	0.00042	0.00136	CcSEcCtD
Cefazolin—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.000417	0.00135	CcSEcCtD
Cefazolin—Hypersensitivity—Epirubicin—thyroid cancer	0.000406	0.00132	CcSEcCtD
Cefazolin—Urticaria—Doxorubicin—thyroid cancer	0.000405	0.00131	CcSEcCtD
Cefazolin—Abdominal pain—Doxorubicin—thyroid cancer	0.000403	0.00131	CcSEcCtD
Cefazolin—Body temperature increased—Doxorubicin—thyroid cancer	0.000403	0.00131	CcSEcCtD
Cefazolin—Asthenia—Epirubicin—thyroid cancer	0.000395	0.00128	CcSEcCtD
Cefazolin—Pruritus—Epirubicin—thyroid cancer	0.00039	0.00126	CcSEcCtD
Cefazolin—Diarrhoea—Epirubicin—thyroid cancer	0.000377	0.00122	CcSEcCtD
Cefazolin—Hypersensitivity—Doxorubicin—thyroid cancer	0.000375	0.00122	CcSEcCtD
Cefazolin—Asthenia—Doxorubicin—thyroid cancer	0.000366	0.00119	CcSEcCtD
Cefazolin—Dizziness—Epirubicin—thyroid cancer	0.000364	0.00118	CcSEcCtD
Cefazolin—Pruritus—Doxorubicin—thyroid cancer	0.00036	0.00117	CcSEcCtD
Cefazolin—Vomiting—Epirubicin—thyroid cancer	0.00035	0.00114	CcSEcCtD
Cefazolin—Diarrhoea—Doxorubicin—thyroid cancer	0.000349	0.00113	CcSEcCtD
Cefazolin—Rash—Epirubicin—thyroid cancer	0.000347	0.00113	CcSEcCtD
Cefazolin—Dermatitis—Epirubicin—thyroid cancer	0.000347	0.00113	CcSEcCtD
Cefazolin—Headache—Epirubicin—thyroid cancer	0.000345	0.00112	CcSEcCtD
Cefazolin—Dizziness—Doxorubicin—thyroid cancer	0.000337	0.00109	CcSEcCtD
Cefazolin—Nausea—Epirubicin—thyroid cancer	0.000327	0.00106	CcSEcCtD
Cefazolin—Vomiting—Doxorubicin—thyroid cancer	0.000324	0.00105	CcSEcCtD
Cefazolin—Rash—Doxorubicin—thyroid cancer	0.000321	0.00104	CcSEcCtD
Cefazolin—Dermatitis—Doxorubicin—thyroid cancer	0.000321	0.00104	CcSEcCtD
Cefazolin—Headache—Doxorubicin—thyroid cancer	0.000319	0.00104	CcSEcCtD
Cefazolin—Nausea—Doxorubicin—thyroid cancer	0.000303	0.000983	CcSEcCtD
